A C C E P T E D M A N U S C R I P T Introduction
Acute heart failure (HF) is a major health care problem affecting nearly one million new patients per year, and is associated with poor clinical outcome. (1,2)(3,4) When chronic kidney disease (CKD), defined as an estimated glomerular filtration rate (eGFR) of <60 mL/min/1.73m 2 , is present in acute HF, it is associated with twofold increased risks of mortality. shown that the mean change in renal function during hospitalization is reflected by an increase in serum creatinine that flattens during a longer inhospital stay, which is thought to be related to the great diversity in renal changes on patient level. (10) However, it is questionable whether this analysis was able to capture the individual heterogeneity of patterns of renal function, as we hypothesize that individual renal trajectories do not all strictly follow the homogeneous population trajectory. Therefore, we evaluated the presence of distinct different individual trajectories of changes in renal function in acute HF, and investigated the association with clinical characteristics and outcome in an analysis from the PROTECT study. In short, 2033 patients with acute (decompensated) heart failure requiring IV diuretic therapy, with mild or moderate renal impairment (estimated creatinine clearance between 20 and 80 mL/min), were randomized to Rolofylline or placebo. The main findings were neutral. Crucial exclusion criteria included a systolic blood pressure <90 or ≥160 mmHg, and ongoing or planned treatment with ultrafiltration or dialysis. All patients provided written informed consent.
A C C E P T E D
For the purpose of this analysis, we included all patients in the intention-to-treat population who were still alive at study day 7, had ≥ 3 serum creatinine measurements taken within the first 7 days of the study, had baseline creatinine measurements, and had additional follow-up for death and rehospitalization of ≥7 days. Using these criteria, the sample size for the present study was 1897 patients of the total study population (93%). Serum creatinine was assessed in a central laboratory (ICON Laboratories, Farmingdale, New York). Subsequently, two researchers (IB and KS) individually assigned each patient of the entire study population to one of the eight trajectories in a blinded matter in a similar procedure.
Afterwards, results were pooled and inconsistencies were solved by consensus, which again included assessment by a third investigator (KD 
Results
Population. The study population consisted of 1897 patients, of which 70% were male, with a mean age of 70±12 years, LVEF of 32±13%, and baseline eGFR of 49±20 ml/min/1.73m 2 .
Median diuretic response over 4 days was -0.39 (-0.80 to -0.14) kg/40 mg furosemide.
Trajectories. First, we identified 8 renal trajectories identified by changes in creatinine, as seen in Figure 1 . These included: a drop followed by a rise ('Dip'), a rise followed by a drop ('Bump'), a 'Dip followed by Bump', a 'Bump followed by Dip', a 'Sustained Decrease', a Changes' trajectory, which probably represents a mixed bag with individual changes in creatinine that on a group level oppose one another, resulting in a horizontal slope.
The distribution of the prevalence of different trajectories is shown in Figure 1 , and ranges from 50 (2.6%) in 'No Change' to 360 (19.0%) in 'Bump'.
Baseline Characteristics. Baseline characteristics of the different trajectories are shown in Table 1 . Overall, characteristics among different trajectories were similar, and only small differences were observed. Notably, patients with trajectory 'No Change' were more likely to be male and had the highest body mass index, while patients with trajectory 'Sustained Increase' were the oldest. Trajectory 'Sustained Decrease' included patients who had the lowest LVEF (31±13%), and most frequently were in NYHA class IV (44%). Mean baseline eGFR, was lowest in this group, with a corresponding creatinine value of 1.60 ( Hemoconcentration, defined as an increase in hemoglobin from admission to day 7 (or discharge) varied between 48% (Drop) and 67% (Pancake), but was not significantly different between trajectories.
Renal trajectories and Clinical outcome.
During follow up, 301 (15.9%) of 1897 patients experienced the primary outcome of all-cause mortality at day 180. Among all renal trajectories, differences in mortality were small and not significantly different. In the trajectory with a sustained increase in creatinine 61 patients (18.3%) experienced the primary endpoint of all-cause mortality. In the trajectory of sustained decrease, which represents the opposite of the sustained increase trajectory, 48 patients
(18.2%) experienced the primary outcome. Notably, the trajectory with an almost absence of change in renal function, 'No Change', had the lowest mortality rate, as 6 patients (12.0%) experienced all-cause mortality at 180 days.
The Kaplan-Meier figure for the primary outcome, mortality at 180 days, among renal trajectories is depicted in Figure 2 (Logrank p-value of 0.51) and showed, in general, similar outcome for all groups.
In Cox regression analysis, using the trajectory 'No Change' as reference category (no change in serum creatinine which showed the best outcome in the Kaplan-Meier survival analysis), the highest mortality risk was observed for both trajectory 'Sustained Decrease' (HR 1.58, 95% Confidence Interval (CI) 0.68 to 3.70) and trajectory 'Sustained Increase' (HR 1.59, 95%
CI 0.69 to 3.68). However, these differences did not reach statistical significance (P-value 0.29 and 0.28, respectively, Table 2 ). Other trajectories showed a similar pattern, without evidence of increased or decreased risk with one particular trajectory.
In multivariable Cox regression analysis, after adjustment for baseline eGFR, similar findings remained ( Table 2) . Whereas eGFR at baseline itself was a powerful predictor of mortality, none of the trajectories showed a significant association with increased mortality rates. Even when adjusted for baseline diuretic response, no significant differences were found. Finally, after adjustment for the 8 -variable multivariable model, the results remained largely unchanged.
The secondary combined endpoint of death or cardiovascular or renal rehospitalization at day 60 ( Figure 3) showed similar results for all trajectories. However, a trend was observed in favor of the fluctuating trajectory 'Various Changes' regarding all the secondary outcomes in unadjusted analyses, whereas trajectory 'No Change' showed the worst outcome. However, in
Cox regression analysis and after multivariable adjustment, no statistically significant differences between the trajectories were observed.
Discussion
This study was designed to identify patterns of changes in renal function during a hospital admission for acute HF, and relate these patterns to different clinical characteristics and outcome. Our results show that despite marked differences in patterns as determined on an individual patient level, differences in clinical characteristics and clinical outcome were small.
Epidemiology of renal trajectories
In acute heart failure, 20-30% of patients experience deterioration or worsening renal function during hospitalization. function on a population level. One possible explanation was put forward by Kataoka, suggesting that 'paradoxical' improvement of renal function, reflected by a decrease in serum creatinine despite worsening heart failure, could be due to inter-individual differences in renal function among patients. Moreover, most studies have used merely two time points of measurements of serum creatinine to quantify changes in renal function, instead of several measurements to form a realistic slope.(5,20,21) Therefore, in this present study we thoroughly evaluated each individual renal trajectory and subsequently identified eight distinct trajectories of changes of renal function. Of these patterns, a rise in creatinine followed by a drop (trajectory 'Bump') was most prevalent, whereas an almost absence of change in creatinine (trajectory 'No Change') was least common. Interestingly, the two most opposing trajectories, a sustained increase versus a sustained decrease, had similar baseline characteristics. Overall, baseline differences between all trajectories were remarkably small, despite the great diversity in the individual changes in renal function patterns. Therefore, it might be difficult to establish specific characteristics that identify patients beforehand which will experience similar patterns of changes in renal function.
Clinical Outcome and patterns of change in renal function
In general, WRF in acute HF has been associated with worse clinical outcome, as it is independently associated with significantly increased mortality and rehospitalization risks. (5, 22) However, this does not directly imply that survival improves if treatment causes improvement of serum creatinine changes. On the contrary, it has been shown that also improved renal function (IRF) as shown by a decrease in serum creatinine is associated with a significant, independent, increased risk of mortality, and WRF in the context of hemoconcentration is not associated with worse outcomes. (7, 18, 23) Furthermore, the important role of individual risk factors and biomarkers is emphasized, as they provide more
prognostic information than the sum of population risk factors. (24) Therefore, this present study investigated the prognostic role of the trajectory of serum creatinine as an individual renal marker. Overall, our study found that differences in all-cause mortality were small, even when adjusted for baseline eGFR. The individual renal pattern that is considered as 'true'
WRF, a continuous increase in creatinine ('Sustained Increased'), had unexpectedly similar outcomes when compared to the opposing trajectory, a constant decrease in creatinine ('Sustained Decrease'), or so called IRF. We were also unable to find other statistically significant differences in clinical outcome for any of the trajectories, for all cause mortality and the secondary outcomes. Although small differences were observed in crude event rates, it is questionable whether this translates into clinically relevant changes. Overall, we found no significant evidence for an increased or decreased risk with one particular trajectory.
Possible explanations and clinical implications
There are several possible explanations for the present findings. One first explanation could be the impact of changes in treatment strategies, which were either based on (changes in) renal function or actually caused the changes in renal function. Cardiologists routinely assess changes in renal function during treatment of acute heart failure, and probably act upon these changes in response to therapy. Our findings are therefore a reflection of the general course of creatinine, together with the effect of (changes in) decongestive strategies. In this way, perhaps, by adjusting therapies, physicians may have overcome some of the excess in risk that has been associated with WRF in acute heart failure. Secondly, it is known that heart failure patients frequently experience deterioration in renal function prior to hospital admission, as well as post-hospital recurrence of renal dysfunction. (18, 25) 
Strengths and limitations
The novelty of this present study is the use of individual patient data to define patterns and trajectories of renal function. Individual patient data most accurately reflect real clinical practice. Nevertheless, this is a post-hoc analysis and our findings should therefore be considered hypothesis generating only. Our study was conducted in a cohort of a randomized serum creatinine since the overall change in creatinine in sensitivity analysis was limited.
Given the large number of defined trajectories, and the known random variation due to the creatinine assay or random sampling variation, the true changes in creatinine in each patient could have been over and underestimated. Finally, to establish more than one fluctuation in creatinine, more than 4 serum creatinine values should be available, therefore, the prevalence of the trajectories 'Various Changes', 'Bump followed by Dip' and 'Dip followed by Bump' may have been underestimated.
Conclusions
Although there are major differences in patterns of changes in renal function during an acute heart failure hospital admission, clinical characteristics and clinical outcome were similar between the trajectories. Our results therefore question the prognostic importance of patterns of changes in renal function in acute heart failure. 
